164 related articles for article (PubMed ID: 27047987)
1. Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis.
Costiniuk CT; Brunet L; Rollet-Kurhajec KC; Cooper CL; Walmsley SL; Gill MJ; Martel-Laferriere V; Klein MB
Open Forum Infect Dis; 2016 Mar; 3(2):ofw050. PubMed ID: 27047987
[TBL] [Abstract][Full Text] [Related]
2. Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis.
Brunet L; Moodie EE; Rollet K; Cooper C; Walmsley S; Potter M; Klein MB;
Clin Infect Dis; 2013 Sep; 57(5):663-70. PubMed ID: 23811492
[TBL] [Abstract][Full Text] [Related]
3. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
[TBL] [Abstract][Full Text] [Related]
4. Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus Coinfection.
Moqueet N; Cooper C; Gill J; Hull M; Platt RW; Klein MB;
J Infect Dis; 2016 Jul; 214(1):80-6. PubMed ID: 26984148
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.
Rollet-Kurhajec KC; Moodie EE; Walmsley S; Cooper C; Pick N; Klein MB;
PLoS One; 2015; 10(6):e0129868. PubMed ID: 26090666
[TBL] [Abstract][Full Text] [Related]
6. Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.
Kelly EM; Dodge JL; Sarkar M; French AL; Tien PC; Glesby MJ; Golub ET; Augenbraun M; Plankey M; Peters MG
Clin Infect Dis; 2016 Aug; 63(4):512-8. PubMed ID: 27225241
[TBL] [Abstract][Full Text] [Related]
7. Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients.
Lo Re V; Kallan MJ; Tate JP; Lim JK; Goetz MB; Klein MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Gibert CL; Brown ST; Park LS; Dubrow R; Reddy KR; Kostman JR; Justice AC; Localio AR
Open Forum Infect Dis; 2015 Sep; 2(3):ofv109. PubMed ID: 26284259
[TBL] [Abstract][Full Text] [Related]
8. Opioid use and risk of liver fibrosis in HIV/hepatitis C virus-coinfected patients in Canada.
Brunet L; Moodie EE; Cox J; Gill J; Cooper C; Walmsley S; Rachlis A; Hull M; Klein MB;
HIV Med; 2016 Jan; 17(1):36-45. PubMed ID: 26140381
[TBL] [Abstract][Full Text] [Related]
9. Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons.
Brunet L; Moodie EEM; Young J; Cox J; Hull M; Cooper C; Walmsley S; Martel-Laferrière V; Rachlis A; Klein MB; ; Cohen J; Conway B; Cooper C; Côté P; Cox J; Gill J; Haider S; Sadr A; Johnston L; Hull M; Montaner J; Moodie E; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall JM; Vachon ML; Sanche S; Skinner S; Wong D
Clin Infect Dis; 2016 Jan; 62(2):242-249. PubMed ID: 26400998
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort.
Ramírez-Mena A; Glass TR; Winter A; Kimera N; Ntamatungiro A; Hatz C; Tanner M; Battegay M; Furrer H; Wandeler G; Letang E
Open Forum Infect Dis; 2016 Sep; 3(3):ofw162. PubMed ID: 27704017
[No Abstract] [Full Text] [Related]
11. Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals.
Bavaro DF; Saracino A; Fiordelisi D; Bruno G; Ladisa N; Monno L; Angarano G
J Med Virol; 2019 May; 91(5):751-757. PubMed ID: 30578670
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients.
Hull MW; Rollet K; Moodie EE; Walmsley S; Cox J; Potter M; Cooper C; Pick N; Saeed S; Klein MB;
AIDS; 2012 Sep; 26(14):1789-94. PubMed ID: 22739388
[TBL] [Abstract][Full Text] [Related]
13. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
[TBL] [Abstract][Full Text] [Related]
15. Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients.
Kliemann DA; Wolff FH; Tovo CV; Alencastro PR; Ikeda ML; Brandão AB; Barcellos N; Fuchs SC
Ann Hepatol; 2016; 15(1):27-32. PubMed ID: 26626637
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus.
Hull MW; Rollet K; Odueyungbo A; Saeed S; Potter M; Cox J; Cooper C; Gill J; Klein MB;
Clin Infect Dis; 2012 Jun; 54(12):1798-805. PubMed ID: 22460964
[TBL] [Abstract][Full Text] [Related]
17. Risk of liver decompensation among HIV/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy.
Macías J; Márquez M; Téllez F; Merino D; Jiménez-Aguilar P; López-Cortés LF; Ortega E; von Wichmann MA; Rivero A; Mancebo M; Santos J; Pérez-Pérez M; Suárez-Lozano I; Romero-Palacios A; Torres-Cornejo A; Pineda JA
Clin Infect Dis; 2013 Nov; 57(10):1401-8. PubMed ID: 23946224
[TBL] [Abstract][Full Text] [Related]
18. Progression of liver fibrosis in HIV/hepatitis C virus-coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline.
Sanmartín R; Tor J; Sanvisens A; López JJ; Jou A; Muga R; Ojanguren I; Barluenga E; Videla S; Planas R; Clotet B; Tural C
HIV Med; 2014 Apr; 15(4):203-12. PubMed ID: 24245909
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.
Merchante N; Macías J; Ramayo E; Vergara S; García-García JA; Mira JA; Corzo JE; Gómez-Mateos JM; Lozano F; Pineda JA
J Viral Hepat; 2006 Jul; 13(7):449-56. PubMed ID: 16792538
[TBL] [Abstract][Full Text] [Related]
20. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
